Real-time enrollment status for this uterine leiomyosarcoma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 2:38 AM UTC
| NCT Number | NCT05649956 |
| Recruiting Status | Recruiting |
| Condition | Uterine Leiomyosarcoma |
| Phase | PHASE2 |
| Target Enrollment | 40 participants |
| Active Locations | 34 sites in the US |
| Sponsor | GOG Foundation |
| Last Updated on CT.gov | July 30, 2026 (Jul 30, 2026) |
As of August 31, 2026: Clinical trial NCT05649956 is currently recruiting participants. This phase2 study for uterine leiomyosarcoma is actively seeking new participants at 34 locations across the United States. The study is sponsored by GOG Foundation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05649956 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 34 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05649956 was last updated Jul 30, 2026 (July 30, 2026). HelloStudys verifies this status automatically.